This report evaluates the clinical utility of genetic testing for fragile X-associated primary ovarian insufficiency (FXPOI). The goal of this report is to assess how genetic testing of women with primary ovarian insufficiency (POI) to diagnose FXPOI changes patient outcomes, alters diagnostic thinking, results in decision-making guidance, and leads to familial and societal impacts. 

If you have a Hayes login, click here to view the full report on the Knowledge Center.